Newborn Screening Market Size, In-depth Analysis Report and Global Forecast to 2027

Newborn Screening Market is anticipated to grow significantly in the forecast period due to increasing need for the detection of metabolic, genetic, and developmental disorders in infants.

For hearing test, either a tiny microphone or earpiece in the baby’s ear, or electrodes are placed on the infant’s head while it is asleep or quiet.

In CCHD screening, a tiny soft sensor attached with oximeter machine is placed on the infant’s skin.

This machine measures the infant’s oxygen level in the hands and foot.

Major factors attributing to the growth of the newborn screening market include increasing government initiatives towards baby health and public health benefits in the developed economies, availability of laboratory sciences and enhanced technologies, increasing investment or innovations in the domain, growing cases of neonatal disorders among infants, and increasing awareness for hereditary disorders in babies.

However, strict regulations in few economies that delay hospitalization and low availability of technologically enhancement in tests and instruments are hampering the newborn screening industry growth.

Newborn Screening Market: IntroductionAccording to the report, the global newborn screening market was valued at ~US$ 940 Mn in 2019 and is projected to expand at a CAGR of ~11% from 2021 to 2031.

Newborn screening helps in the early detection of serious genetic diseases, which may result in disability or death if not treated at the initial stage.

Different types of instrument and assay kits are used in the diagnosis of newborn disorders.

Hearing screening devices and pulse oximeter are regularly used in the diagnosis of newborn disorders.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=4581The growth of the global newborn screening market can be ascribed to the rise in prevalence of critical congenital heart defects and government support.

The U.S. has a national program of newborn screening tests to check for several different disorders that can be treated, if found very early in life.North America dominated the global newborn screening market in 2019.

According to the Indian Academy of Pediatrics, more than 200,000 children are estimated to be born with CHD in India every year.

Prenatal Testing & Newborn Screening Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.

The chapter on the impact – both negative and positive – of COVID-19 on the prenatal testing & newborn screening industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.

This includes revised market numbers according to the effects of the coronavirus and the expected prenatal testing & newborn screening market growth numbers 2021-2030.View Complete Report:https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report-2020-30-covid-19-growth-and-changeThe Prenatal Testing & Newborn Screening Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global prenatal testing & newborn screening market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030.

The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.The Prenatal Testing & Newborn Screening Global Market Report 2021 covers prenatal testing & newborn screening market drivers, prenatal testing & newborn screening market trends, prenatal testing & newborn screening market growth rate, prenatal testing & newborn screening market major players, player-adopted strategies in the market, and prenatal testing & newborn screening market size.The global prenatal testing & newborn screening market is expected to grow from $4.178 billion in 2020 to $4.679 billion in 2021 at a compound annual growth rate (CAGR) of 12%.

The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.

The market is expected to reach $8.018 billion in 2025 at a CAGR of 14%.Request For The Sample Now: https://www.thebusinessresearchcompany.com/sample.aspx?id=3350=smpThe report covers the prenatal testing & newborn screening market segments- 1) By Diagnostic Type: Non-Invasive, Invasive 2) By Technology: Screening Technology, Diagnostic Technology 3) By End User: Hospitals, Diagnostic CentersAbout The Business Research Company:  The Business Research Company is a market intelligence firm that excels in company, market, and consumer research.

The global Newborn Screening Market is anticipated to grow significantly in the forecast period due to increasing need for the detection of metabolic, genetic, and developmental disorders in infants.

Early detection and treatment reduces or prevents the risk of physical and intellectual disabilities, and also life threatening disorders in infants.

For blood test, few blood drops are taken from the infant’s heels and is sent to the lab for analysis.

In CCHD screening, a tiny soft sensor attached with oximeter machine is placed on the infant’s skin.

Download Free Sample Report @ https://www.millioninsights.com/industry-reports/newborn-screening-market/request-sample Major factors attributing to the growth of the newborn screening market include increasing government initiatives towards baby health and public health benefits in the developed economies, availability of laboratory sciences and enhanced technologies, increasing investment or innovations in the domain, growing cases of neonatal disorders among infants, and increasing awareness for hereditary disorders in babies.

The major players operating in the domain include Trivitron Healthcare, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Masimo Corporation, Bio-Rad Laboratories, PerkinElmer Inc., General Electric Healthcare, Natus Medical Incorporated, and Waters Corporation.

The Business Research Company published its Prenatal Testing And Newborn Screening Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Prenatal Testing And Newborn Screening market.

The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the prenatal testing and newborn screening market’s segments-1) By Diagnostic Type: Non-Invasive, Invasive2) By Technology: Screening Technology, Diagnostic Technology3) By End user: Hospitals, Diagnostic centers.

View Complete Report:https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report-2020-30-covid-19-growth-and-changePrenatal Testing And Newborn Screening Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.

The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.

The decline is mainly due to the COVID-19 outbreak that has led to deferred care in order to avoid visiting hospitals, which resulted in reduced patient volume.

The market is then expected to recover and reach $6.04 billion in 2023 at a CAGR of 13.09%.The use of machine learning and artificial intelligence is gradually gaining popularity in the prenatal testing and newborn screening market.

New York, NY 20 May 2021: The global dried blood spot collection cards market expected to reach USD 339.5 million by 2027 according to a new study by Polaris Market Research.

The report “Dried Blood Spot Collection Cards Market Share, Size, Trends, Industry Analysis Report, By Card Type (Whatman 903, Ahlstrom 226, FTA, Others); By Application (Newborn Screening, Infectious Disease Testing, Therapeutic Drug Monitoring, Forensics, Others); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The recent surge in COVID-19 pandemic, rising newborn screening through dried blood spot collection cards for hereditary and metabolic disorders, innovations, and its wide applicability in diagnosing varied diseases coupled with new product launches are few factors attributed to the market growth for dried blood spot collection cards.

For instance, in June 2020, PerkinElmer Inc. introduced the DBS test for COVID-19 in the market utilizing its DELFIA platform with a capacity of up to 5,000 samples in a day.

This sample collection allows both de-centralized collection and efficient testing.

Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/dried-blood-spot-collection-cards-market/request-for-sample Segment HighlightsThe Whatman 903 dried blood spot collection cards industry segment accounted for the largest revenue share in 2019 owing to the emergence and increasing incidences of genetic disorders.